Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINTER
NCT07843537Phase 2Not yet recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2027
- Primary completion
- Mar 2030
- Countries
- 1
01
Overview
A Phase 2 trial of disulfiram, copper gluconate in thoracic cancer, sponsored by University of Texas MD Anderson Cancer Center. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
disulfiramcopper gluconate
03
Conditions
thoracic cancer
Beyond the preview
Go deeper on NCT07843537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843537.